Related Experiment Video
Updated: Mar 8, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer
Mahmoud A Alfaqih1,2, Erik R Nelson2,3, Wen Liu2
1Department of Surgery, Duke University, Durham, North Carolina.
Abstract:
In this study, we used a bioinformatic approach to identify genes whose expression is dysregulated in human prostate cancers. One of the most dramatically downregulated genes identified encodes CYP27A1, an enzyme involved in regulating cellular cholesterol homeostasis. Importantly, lower CYP27A1 transcript levels were associated with shorter disease-free survival and higher tumor grade. Loss of CYP27A1 in prostate cancer was confirmed at the protein level by immunostaining for CYP27A1 in annotated tissue microarrays. Restoration of CYP27A1 expression in cells where its gene was silenced attenuated their growth in vitro and in tumor xenografts. Studies performed in vitro revealed that treatment of prostate cancer cells with 27-hydroxycholesterol (27HC), an enzymatic product of CYP27A1, reduced cellular cholesterol content in prostate cancer cell lines by inhibiting the activation of sterol regulatory-element binding protein 2 and downregulating low-density lipoprotein receptor expression. Our findings suggest that CYP27A1 is a critical cellular cholesterol sensor in prostate cells and that dysregulation of the CYP27A1/27HC axis contributes significantly to prostate cancer pathogenesis. Cancer Res; 77(7); 1662-73. ©2017 AACR.
Insights
The enzyme CYP27A1, crucial for cholesterol balance, is downregulated in prostate cancer, correlating with poorer survival. Restoring CYP27A1 inhibits cancer cell growth, suggesting its role in disease progression.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Prostate cancer progression is linked to altered gene expression.
- Cholesterol homeostasis plays a role in cancer development.
- CYP27A1 is an enzyme involved in cholesterol metabolism.
Purpose of the Study:
- To identify genes dysregulated in prostate cancer.
- To investigate the role of CYP27A1 in prostate cancer pathogenesis.
- To explore the therapeutic potential of targeting the CYP27A1/27HC axis.
Main Methods:
- Bioinformatic analysis of gene expression in prostate cancer.
- Immunohistochemical staining of CYP27A1 in tissue microarrays.
- In vitro and in vivo studies of CYP27A1 restoration in cancer cells.
- In vitro studies on the effects of 27-hydroxycholesterol (27HC) on prostate cancer cells.
Main Results:
- CYP27A1 was identified as a significantly downregulated gene in prostate cancer.
- Lower CYP27A1 levels correlated with reduced disease-free survival and higher tumor grade.
- Restoring CYP27A1 expression suppressed prostate cancer cell growth in vitro and in vivo.
- 27HC treatment reduced cellular cholesterol by inhibiting SREBP-2 activation and LDL receptor expression.
Conclusions:
- CYP27A1 functions as a critical cellular cholesterol sensor in prostate cells.
- Dysregulation of the CYP27A1/27HC pathway contributes to prostate cancer development.
- Targeting the CYP27A1/27HC axis may offer a novel therapeutic strategy for prostate cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Negative Regulator Molecules
Inhibition of Cdk Activity
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

